CoChat

Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: Multi-center open trial

Kanauchi, Osamu, Mitsuyama, Keiichi, Homma, Terasu, Takahama, Kazuya, Fujiyama, Yoshihide, Andoh, Akira, Araki, Yoshio, Suga, Toshihiro, Hibi, Toshifumi, Naganuma, Makoto, Asakura, Hitoshi, Nakano, Hiroshi, Shimoyama, Takashi, Hida, Nobuyuki, Haruma, Ken, Koga, Hideki, Sata, Michio, Tomiyasu, Nobuo, Toyonaga, Atsushi, Fukuda, Masanobu, Kojima, Atsushi, Bamba, Tadao · 2003 · International Journal of Molecular Medicine
Cited by 137

The DOI matches its Crossref record.

Abstract

Germinated barley foodstuff (GBF), which mainly consists of dietary fiber and glutamine-rich protein, is a prebiotic for ulcerative colitis (UC). In our previous study, we carried out a clinical trial of GBF with mildly to moderately active UC patients and showed that GBF treatment was able to attenuate the symptoms of UC in a relatively short-term. The aim of this study was to investigate the efficacy of long-term administration of GBF in the treatment of UC in a multi-center open trial. Twenty-one patients with mildly to moderately active UC received 20-30 g of GBF for 24 weeks in an open-label protocol while baseline treatments (5-amino-salicyrate compounds and/or steroids) were continued. The response to the GBF treatment was evaluated using a clinical scoring and after 24 weeks of observation, the GBF group showed a significant decrease in clinical activity index (especially, the degree of visible blood in stools and the presence of nocturnal diarrhea) compared with the control group (p<0.05). No side effects related to GBF were observed. In conclusion, GBF can reduce the clinical activity of UC over long-term as well as short-term administration. Nutraceutical GBF therapy may have a place in long-term management of UC, but controlled studies are needed to demonstrate its efficacy in the treatment of this disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/ijmm.12.5.701

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 137

Metadata

Authors
Kanauchi, O., Mitsuyama, K., Homma, T., Takahama, K., Fujiyama, Y., Andoh, A., Araki, Y., Suga, T., Hibi, T., Naganuma, M., Asakura, H., Nakano, H., Shimoyama, T., Hida, N., Haruma, K., Koga, H., Sata, M., Tomiyasu, N., Toyonaga, A., Fukuda, M., Kojima, A., & Bamba, T.
Venue
International Journal of Molecular Medicine
Published
2003-11-01
Volume
12
Issue
5
Pages
701-4
ISSN
  • 1107-3756 (ISSN-L)
  • 1791-244X
OpenAlex
W2009534457
Cited by
137
References
0
FWCI
3.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: Multi-center open trial. https://app.cochat.ai/papers/10.3892/ijmm.12.5.701
The paper
Kanauchi, O., Mitsuyama, K., Homma, T., Takahama, K., Fujiyama, Y., Andoh, A., Araki, Y., Suga, T., Hibi, T., Naganuma, M., Asakura, H., Nakano, H., Shimoyama, T., Hida, N., Haruma, K., Koga, H., Sata, M., Tomiyasu, N., Toyonaga, A., . . . Bamba, T. (2003). Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: Multi-center open trial. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.12.5.701

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.